SEARCH

SEARCH BY CITATION

References

  • Adeyeye CM, Bricker JD, Vilivalam VD, Smith WI (1996). Acute gastrointestinal toxic effects of suspensions of unencapsulated and encapsulated ibuprofen in rats. Pharm Res 13: 784793.
  • Akaogi J, Nozaki T, Satoh M, Yamada H (2006). Role of PGE2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy. Endocr Metab Immune Disord Drug Targets 6: 383394.
  • Alamanos Y, Drosos AA (2005). Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 4: 130136.
  • Bendele A (2001). Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact 1: 377385.
  • Bendele A, McComb J, Gould T, McAbee T, Sennello G, Chlipala E et al. (1999). Animal models of arthritis: relevance to human disease. Toxicol Pathol 27: 134142.
  • Boyce BF, Yao Z, Xing L (2010). Functions of nuclear factor kappaB in bone. Ann N Y Acad Sci 1192: 367375.
  • Brown KD, Claudio E, Siebenlist U (2008). The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther 10: 212.
  • Brunner E, Domhof S, Langer F (2002). Nonparametric Analysis of Longitudinal Data in Factorial Designs. Wiley: New York.
  • Cicala C, Ianaro A, Fiorucci S, Calignano A, Bucci M, Gerli R et al. (2000). NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol 130: 13991405.
  • Conway JG, Andrews RC, Beaudet B, Bickett DM, Boncek V, Brodie TA et al. (2001). Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases. J Pharmacol Exp Ther 298: 900908.
  • Dayer JM (2003). The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Rheumatology 42 (Suppl. 2): ii3i10.
  • Eurenius E, Stenstrom CH (2005). Physical activity, physical fitness, and general health perception among individuals with rheumatoid arthritis. Arthritis Rheum 53: 4855.
  • Fahmi H (2004). mPGES-1 as a novel target for arthritis. Curr Opin Rheumatol 16: 623627.
  • Feldmann M, Brennan FM, Maini RN (1996). Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14: 397440.
  • Hamberg M, Samuelsson B (1971). On the metabolism of prostaglandins E 1 and E 2 in man. J Biol Chem 246: 67136721.
  • Hayashida K, Kaneko T, Takeuchi T, Shimizu H, Ando K, Harada E (2004). Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J Vet Med Sci 66: 149154.
  • Hikiji H, Takato T, Shimizu T, Ishii S (2008). The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease. Prog Lipid Res 47: 107126.
  • Hyman BT, Stoll LL, Spector AA (1982). Prostaglandin production by 3T3-L1 cells in culture. Biochim Biophys Acta 713: 375385.
  • Karin M (2009). NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 1: a000141.
  • Kishimoto T (2005). Interleukin-6: from basic science to medicine – 40 years in immunology. Annu Rev Immunol 23: 121.
  • Kunz M, Ibrahim SM (2009). Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm 2009: 979258.
  • Lichtman SN, Wang J, Lemasters JJ (1998). LPS receptor CD14 participates in release of TNF-alpha in RAW 264.7 and peritoneal cells but not in kupffer cells. Am J Physiol 275: G39G46.
  • McCoy JM, Wicks JR, Audoly LP (2002). The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest 110: 651658.
  • Mackenzie GG, Sun Y, Huang L, Xie G, Ouyang N, Gupta RC et al. (2010). Phospho-sulindac (OXT-328), a novel sulindac derivative, is safe and effective in colon cancer prevention in mice. Gastroenterology 139: 13201332.
  • Monaco C, Andreakos E, Kiriakidis S, Feldmann M, Paleolog E (2004). T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases. Curr Drug Targets Inflamm Allergy 3: 3542.
  • Nemmani KV, Mali SV, Borhade N, Pathan AR, Karwa M, Pamidiboina V et al. (2009). NO-NSAIDs: gastric-sparing nitric oxide-releasable prodrugs of non-steroidal anti-inflammatory drugs. Bioorg Med Chem Lett 19: 52975301.
  • Pearson CM, Waksman BH, Sharp JT (1961). Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. V. Changes affecting the skin and mucous membranes. Comparison of the experimental process with human disease. J Exp Med 113: 485510.
  • Philippe L, Gegout-Pottie P, Guingamp C, Bordji K, Terlain B, Netter P et al. (1997). Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats. Am J Physiol 273: R1550R1556.
  • Piazza GA, Keeton AB, Tinsley HN, Gary BD, Whitt JD, Mathew B et al. (2009). A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity. Cancer Prev Res 2: 572580.
  • Rahme E, Bernatsky S (2010). NSAIDs and risk of lower gastrointestinal bleeding. Lancet 376: 146148.
  • Rigas B (2007). The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia. Curr Opin Gastroenterol 23: 5559.
  • Roberts J II, Morrow J (2001). Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment gout. In: Hardman JG, Limbird LE (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th edn. McGraw-Hill: New York, pp. 687731.
  • Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A et al. (2000). Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284: 12471255.
  • Singh G, Triadafilopoulos G (1999). Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol 26 (Suppl. 56): 1824.
  • Sostres C, Gargallo CJ, Arroyo MT, Lanas A (2010). Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol 24: 121132.
  • Sun Y, Rigas B (2008). The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents. Cancer Res 68: 82698277.
  • Theisen-Popp P, Muller-Peddinghaus R (1994). Antirheumatic drug profiles evaluated in the adjuvant arthritis of rats by multiparameter analysis. Agents Actions 42: 5055.
  • Whiteley PE, Dalrymple SA (1998). Models of inflammation: measuring gastrointestinal ulcerations in the rat. In: Enna SJ (ed.). Current Protocols in Pharmacology, Vol. 3. John Wiley & Sons, Inc: New York, pp. 10.2.110.2.4.
  • Whiteley PE, Dalrymple SA (2001). Models of inflammation: adjuvant-induced arthritis in the rat. In: Enna SJ (ed.). Current Protocols in Pharmacology, Vol. 2. John Wiley & Sons, Inc: New York, pp. 5.5.15.5.5.
  • Zhao W, Mackenzie GG, Murray OT, Zhang Z, Rigas B (2009). Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect. Carcinogenesis 30: 512519.